D.E. Shaw & Co
BLU

D.E. Shaw & Co’s BELLUS Health Inc. BLU Stock Holding History

D.E. Shaw & Co’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-73,421
Closed -$529K – 4737
2023
Q1 		$529K Sell
73,421
-361,892
-83% -$2.81M ﹤0.01% 3524
2022
Q4 		$3.58M Sell
435,313
-133,708
-23% -$1.25M ﹤0.01% 2399
2022
Q3 		$6.01M Buy
+569,021
New +$6.05M 0.01% 1880
2022
Q1 		– Sell
-56,713
Closed -$457K – 6131
2021
Q4 		$457K Buy
+56,713
New +$376K ﹤0.01% 4453
2021
Q1 		– Sell
-10,452
Closed -$32K – 4590
2020
Q4 		$32K Buy
+10,452
New +$28.3K ﹤0.01% 3859

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

D.E. Shaw & Co's BLU Position: Q2 2023 in Review

D.E. Shaw & Co sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 73,421 shares — an estimated $529K sold.

D.E. Shaw & Co first reported a position in BLU in Q4 2020 and held it in 5 quarters. The position peaked at $6.01M in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • D.E. Shaw & Co reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • D.E. Shaw & Co sold 73,421 BELLUS Health Inc. shares in Q2 2023, an estimated $529K.
  • D.E. Shaw & Co first reported a position in BELLUS Health Inc. in Q4 2020 and held it in 5 quarters.
  • D.E. Shaw & Co's BELLUS Health Inc. position peaked at $6.01M in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on D.E. Shaw & Co's 13F filing for Q2 2023, filed 14 Aug 2023.